PharmaCyte Biotech Inc (PMCB)

[Gmc2020]

Let's cut to the chase:
If you are long like myself, Nvlx is an all or nothing bet. If it get FDA approval for pancreatic cancer the PPS will jump, but that's not the long perspective. If it gets approval it will have the financing to expand to diabetics and other applications... Meaning big potential, but this won't happen for years. If you are following this company on a daily basis ... Or even weekly you probably bought more than you can afford to loose.

The price shot up to .62 because of the massive amount of investors who thought they could get rich fast.... Not long term investors.

If you are a trader there is a lot of money to be made too. This stock will have 40% gains and losses several times before it succeeds or fails.

Both shorts and longs have a fairly equal chance to win big. Approval of pancreatic treatment will tip the scale in favor of the longs... If it fails to get FDA approval nvlx will not be able to pursue it's other potential revenue streams.

As of now we wait. Good luck to all. Short or long ... Don't bet more than you can lose!